Understanding diabetes medications from the perspective of patients with type 2 diabetes

Prerequisite to medication concordance

Risa P. Hayes, Lee Bowman, Patrick Monahan, David Marrero, Colleen A. McHorney

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Purpose: The purpose of this qualitative study was to explore diabetes medication experiences of patients with type 2 diabetes. Methods: Study participants were recruited through newspaper advertisements and letters from primary and specialty clinics in Indianapolis, Indiana. The same professional facilitator conducted 18 focus groups (7 male, 11 female) at a Veteran Affairs facility in Indianapolis, Indiana. Participants were 138 socioeconomically diverse individuals with type 2 diabetes (68% female, 74% ≥ 50 years old, 61% non-Hispanic Caucasian). Participants were on a variety of diabetes medication regimens (61% injectable insulin monotherapy or in combination with orals). Content analysis of focus group transcripts was used to establish themes. Results: Three major themes emerged across the focus groups: (1) the inconvenience and inflexibility of the timing and frequency of administration of many diabetes treatments on participants' lives, (2) the desire to avoid injections and/or insulin therapy, and (3) the physical and emotional side effects of diabetes medications. Assuming equivalent effectiveness of 2 medications, participants would weigh the convenience and flexibility, route of administration, side effects, and cost of the medications to arrive at a treatment preference. Participants believed they currently had no opportunity to express their treatment preference to their health care provider. Conclusions: The best therapeutic option for a patient with type 2 diabetes will be one that is clinically effective and consistent with the patient's needs and preferences. The challenge for diabetes educators is to support patients in articulating and incorporating their needs and preferences into the treatment decision-making process.

Original languageEnglish
Pages (from-to)404-414
Number of pages11
JournalDiabetes Educator
Volume32
Issue number3
DOIs
StatePublished - May 2006

Fingerprint

Type 2 Diabetes Mellitus
Focus Groups
Therapeutics
Insulin
Injections
Newspapers
Patient Preference
Veterans
Health Personnel
Decision Making
Costs and Cost Analysis

ASJC Scopus subject areas

  • Internal Medicine
  • Public Health, Environmental and Occupational Health
  • Endocrinology, Diabetes and Metabolism

Cite this

Understanding diabetes medications from the perspective of patients with type 2 diabetes : Prerequisite to medication concordance. / Hayes, Risa P.; Bowman, Lee; Monahan, Patrick; Marrero, David; McHorney, Colleen A.

In: Diabetes Educator, Vol. 32, No. 3, 05.2006, p. 404-414.

Research output: Contribution to journalArticle

@article{34d12fa7bd3e41e1a1c7ccc10b65c8a7,
title = "Understanding diabetes medications from the perspective of patients with type 2 diabetes: Prerequisite to medication concordance",
abstract = "Purpose: The purpose of this qualitative study was to explore diabetes medication experiences of patients with type 2 diabetes. Methods: Study participants were recruited through newspaper advertisements and letters from primary and specialty clinics in Indianapolis, Indiana. The same professional facilitator conducted 18 focus groups (7 male, 11 female) at a Veteran Affairs facility in Indianapolis, Indiana. Participants were 138 socioeconomically diverse individuals with type 2 diabetes (68{\%} female, 74{\%} ≥ 50 years old, 61{\%} non-Hispanic Caucasian). Participants were on a variety of diabetes medication regimens (61{\%} injectable insulin monotherapy or in combination with orals). Content analysis of focus group transcripts was used to establish themes. Results: Three major themes emerged across the focus groups: (1) the inconvenience and inflexibility of the timing and frequency of administration of many diabetes treatments on participants' lives, (2) the desire to avoid injections and/or insulin therapy, and (3) the physical and emotional side effects of diabetes medications. Assuming equivalent effectiveness of 2 medications, participants would weigh the convenience and flexibility, route of administration, side effects, and cost of the medications to arrive at a treatment preference. Participants believed they currently had no opportunity to express their treatment preference to their health care provider. Conclusions: The best therapeutic option for a patient with type 2 diabetes will be one that is clinically effective and consistent with the patient's needs and preferences. The challenge for diabetes educators is to support patients in articulating and incorporating their needs and preferences into the treatment decision-making process.",
author = "Hayes, {Risa P.} and Lee Bowman and Patrick Monahan and David Marrero and McHorney, {Colleen A.}",
year = "2006",
month = "5",
doi = "10.1177/0145721706288182",
language = "English",
volume = "32",
pages = "404--414",
journal = "Diabetes Educator",
issn = "0145-7217",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Understanding diabetes medications from the perspective of patients with type 2 diabetes

T2 - Prerequisite to medication concordance

AU - Hayes, Risa P.

AU - Bowman, Lee

AU - Monahan, Patrick

AU - Marrero, David

AU - McHorney, Colleen A.

PY - 2006/5

Y1 - 2006/5

N2 - Purpose: The purpose of this qualitative study was to explore diabetes medication experiences of patients with type 2 diabetes. Methods: Study participants were recruited through newspaper advertisements and letters from primary and specialty clinics in Indianapolis, Indiana. The same professional facilitator conducted 18 focus groups (7 male, 11 female) at a Veteran Affairs facility in Indianapolis, Indiana. Participants were 138 socioeconomically diverse individuals with type 2 diabetes (68% female, 74% ≥ 50 years old, 61% non-Hispanic Caucasian). Participants were on a variety of diabetes medication regimens (61% injectable insulin monotherapy or in combination with orals). Content analysis of focus group transcripts was used to establish themes. Results: Three major themes emerged across the focus groups: (1) the inconvenience and inflexibility of the timing and frequency of administration of many diabetes treatments on participants' lives, (2) the desire to avoid injections and/or insulin therapy, and (3) the physical and emotional side effects of diabetes medications. Assuming equivalent effectiveness of 2 medications, participants would weigh the convenience and flexibility, route of administration, side effects, and cost of the medications to arrive at a treatment preference. Participants believed they currently had no opportunity to express their treatment preference to their health care provider. Conclusions: The best therapeutic option for a patient with type 2 diabetes will be one that is clinically effective and consistent with the patient's needs and preferences. The challenge for diabetes educators is to support patients in articulating and incorporating their needs and preferences into the treatment decision-making process.

AB - Purpose: The purpose of this qualitative study was to explore diabetes medication experiences of patients with type 2 diabetes. Methods: Study participants were recruited through newspaper advertisements and letters from primary and specialty clinics in Indianapolis, Indiana. The same professional facilitator conducted 18 focus groups (7 male, 11 female) at a Veteran Affairs facility in Indianapolis, Indiana. Participants were 138 socioeconomically diverse individuals with type 2 diabetes (68% female, 74% ≥ 50 years old, 61% non-Hispanic Caucasian). Participants were on a variety of diabetes medication regimens (61% injectable insulin monotherapy or in combination with orals). Content analysis of focus group transcripts was used to establish themes. Results: Three major themes emerged across the focus groups: (1) the inconvenience and inflexibility of the timing and frequency of administration of many diabetes treatments on participants' lives, (2) the desire to avoid injections and/or insulin therapy, and (3) the physical and emotional side effects of diabetes medications. Assuming equivalent effectiveness of 2 medications, participants would weigh the convenience and flexibility, route of administration, side effects, and cost of the medications to arrive at a treatment preference. Participants believed they currently had no opportunity to express their treatment preference to their health care provider. Conclusions: The best therapeutic option for a patient with type 2 diabetes will be one that is clinically effective and consistent with the patient's needs and preferences. The challenge for diabetes educators is to support patients in articulating and incorporating their needs and preferences into the treatment decision-making process.

UR - http://www.scopus.com/inward/record.url?scp=33744521154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744521154&partnerID=8YFLogxK

U2 - 10.1177/0145721706288182

DO - 10.1177/0145721706288182

M3 - Article

VL - 32

SP - 404

EP - 414

JO - Diabetes Educator

JF - Diabetes Educator

SN - 0145-7217

IS - 3

ER -